Skip to main content
. Author manuscript; available in PMC: 2007 Jan 22.
Published in final edited form as: Eur J Neurosci. 2006 May;23(10):2635–2647. doi: 10.1111/j.1460-9568.2006.04805.x

Fig. 12.

Fig. 12

Kaplan–Meier survival analysis of CD-1 mice prophylactically treated with a single dose of Mab 7D9 administered immediately after intraperitoneal exposure to 22L brain homogenate. Animals which received Mab 7D9 showed a statically significant delay in onset of neurological symptoms compared to those which received an equivalent dose of IgG. Log rank test indicates a statistically significant difference between the groups (P < 0.0001).